Clinical trial
Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients
NCT00001320 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00001320 |
|---|---|
| Title | Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients |
| Official title | I-123 Iodobenzamide (IBZM) SPECT Studies of D2 Receptor Distribution and Function in Patients With Schizophrenia and Normal Volunteers |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy, Schizophrenia |
| Enrollment | 265 |
| Start date | Oct 1, 1991 |
| Completion | Jul 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: